These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8564614)

  • 1. Criteria for use of atovaquone oral suspension in adult inpatients and outpatients.
    Goodwin SD; Fish DN
    Am J Health Syst Pharm; 1995 Nov; 52(21):2460-2. PubMed ID: 8564614
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiparasitic agent atovaquone.
    Baggish AL; Hill DR
    Antimicrob Agents Chemother; 2002 May; 46(5):1163-73. PubMed ID: 11959541
    [No Abstract]   [Full Text] [Related]  

  • 3. Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.
    Spencer CM; Goa KL
    Drugs; 1995 Jul; 50(1):176-96. PubMed ID: 7588086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone.
    Ungvarski P
    J Assoc Nurses AIDS Care; 1993; 4(2):60-2. PubMed ID: 8369502
    [No Abstract]   [Full Text] [Related]  

  • 5. Atovaquone: a review.
    Haile LG; Flaherty JF
    Ann Pharmacother; 1993 Dec; 27(12):1488-94. PubMed ID: 8305784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia.
    Clin Pharm; 1993 Mar; 12(3):175-6. PubMed ID: 8491073
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of atovaquone in the treatment of cerebral toxoplasmosis.
    Durand JM; Cretel E; Bagneres D; Guillemot E; Kaplanski G; Soubeyrand J
    AIDS; 1995 Jul; 9(7):812-3. PubMed ID: 7546430
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
    Brun-Pascaud M; Chau F; Rajagopalan-Levasseur P; Derouin F; Girard PM
    J Eukaryot Microbiol; 1996; 43(5):14S-15S. PubMed ID: 8822822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of atovaquone in resistant toxoplasmosis in AIDS].
    Lafeuillade A; Pellegrino P; Poggi C; Profizi N; Quilichini R; Chouette I; Navarreté MS
    Presse Med; 1993 Oct; 22(33):1708. PubMed ID: 8278330
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
    Hughes WT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):247-52. PubMed ID: 7859136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone: a new oral treatment for pneumocystis.
    Nurse Pract; 1993 Sep; 18(9):22. PubMed ID: 8414230
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment IND protocol announced for Pneumocystis carinii pneumonia.
    Clin Pharm; 1992 Feb; 11(2):99, 103. PubMed ID: 1551304
    [No Abstract]   [Full Text] [Related]  

  • 13. Atovaquone for Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
    [No Abstract]   [Full Text] [Related]  

  • 14. Atovaquone for Pneumocystis carinii pneumonia.
    Stoeckle M; Tennenberg A
    Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825772
    [No Abstract]   [Full Text] [Related]  

  • 15. Atovaquone for Pneumocystis carinii pneumonia.
    Lederman MM; van der Horst C
    Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825771
    [No Abstract]   [Full Text] [Related]  

  • 16. Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients.
    Rosenberg DM; McCarthy W; Slavinsky J; Chan CK; Montaner J; Braun J; Dohn MN; Caldwell PT
    AIDS; 2001 Jan; 15(2):211-4. PubMed ID: 11216929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia.
    Epstein LJ; Mohsenifar Z; Daar ES; Yeh V; Meyer RD
    Am J Med Sci; 1994 Jul; 308(1):5-8. PubMed ID: 8010339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone: a new antipneumocystis agent.
    Artymowicz RJ; James VE
    Clin Pharm; 1993 Aug; 12(8):563-70. PubMed ID: 8222520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia.
    Hughes WT
    Ann Intern Med; 1992 Jun; 116(11):953-4. PubMed ID: 1580456
    [No Abstract]   [Full Text] [Related]  

  • 20. Atovaquone as prophylaxis for Pneumocystis carinii.
    Vilar FJ; McKendrick MW; Nash C
    Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.